They represent different research priorities that may ultimately serve different patient populations best
The trial included 3,183 patients with type 2 diabetes and established cardiovascular disease, chronic kidney disease, or both, who were randomized to receive either oral semaglutide (14 mg) once daily or placebo
Avadel CNS Pharmaceuticals addressed a different category of improper Orange Book listings: the court held that a patent on a computerized risk evaluation and mitigation strategy (REMS) system for a drug should not have been listed in the Orange Book
Ferrannini, E., Rosenbaum, M
Its role exhibits context-dependent duality, functioning as a cytoprotective mechanism or contributing to regulated cell death (Zeng et al., 2019